Outcomes Among Coronary Artery Disease Patients Undergoing PCI with Ridaforolimus-Eluting Stents: A Proportional Meta-Analysis
{{output}}
Background Drug-eluting stents (DES) have become increasingly valuable in the management of coronary artery disease. Ridaforolimus-eluting stents (RES) are a novel DES, an analog of sirolimus with a similar mode of action. Our objective is to evaluate the effi... ...
